April - June 2012
May 21, 2012
Takeda Pharmaceutical Company Limited
Osaka, Japan, May 21, 2012 - Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it has been included for the eighth consecutive year in “the FTSE4Good Global Index of the FTSE4Good Index Series”, which is one of the world’s premier indices for Socially Responsible Investment (SRI)*.
Provided by the FTSE Group**, the FTSE4Good Global Index is a benchmark SRI index and is one of the most important indices for investors, who take into consideration corporate social responsibility (CSR) initiatives of each company, when making investment decision. The FTSE Group applies its own set of social and environmental criteria*** for selection from some 2,400 companies in 25 countries. As of March 31, 2012, 730 companies were included, 181 of which are Japanese. Takeda has once again been selected for this Index for having met FTSE’s criteria in the areas of “Environmental Management”, “Climate Change”, “Human and Labour Rights.”, and “Countering Bribery”.
In addition to the FTSE4Good Global Index, Takeda has also been included in Morningstar Socially Responsible Investment Index (MS-SRI) compiled by Morningstar Japan K.K. since 2009, and Dow Jones Sustainability Asia Pacific Index, jointly compiled by Dow Jones & Company of the United States and Sustainable Asset Management (SAM) AG of Switzerland since 2010, both of which are also benchmark SRI indexes.
As a pharmaceutical company committed to improving people’s lives, Takeda will continue fulfilling its social responsibility as a global entity, with a view towards realizing its Mission, “We strive towards better health for patients worldwide through leading innovation in medicine.”.